Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 21.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXWGet Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 6,400 shares, a drop of 21.0% from the December 31st total of 8,100 shares. Based on an average daily volume of 5,500 shares, the short-interest ratio is currently 1.2 days.

Lexaria Bioscience Trading Down 13.7 %

Lexaria Bioscience stock traded down $0.06 during mid-day trading on Friday, reaching $0.38. The stock had a trading volume of 3,172 shares, compared to its average volume of 8,534. Lexaria Bioscience has a fifty-two week low of $0.38 and a fifty-two week high of $2.50. The stock’s 50-day simple moving average is $0.68 and its 200-day simple moving average is $0.89.

Lexaria Bioscience Company Profile

(Get Free Report)

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.

Featured Stories

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.